Roche Diagnostics plans to bring a fully automated mass spectrometry-based clinical analyzer to market in 2024.

On January 5, 2023, Guangzhou Darui Biotechnology Co., Ltd., the subsidiary of Daan Gene Co., Ltd., received China National Medical Products Administration (NMPA) class III medical device approval for its “Twenty Genetic Deafness Genes Mutation Detection Kit (Time of Flight Mass Spectrometry)”.

Recently, the QuanNUA mass spectrometry system independently developed and manufactured by Intelligene Biosystems (Qingdao) Co., Ltd., the strategic partner of Bioperfectus Technologies, has successfully passed the inspection of Science and Technology Research Center of China Customs.

The development of new scientific ways to see more deeply into the building blocks of nature on a cellular level has led to the some of the greatest advances in medicine over the last century.

On September 13, 2021, Guangzhou Hexin Instrument Co., Ltd. was listed on SSE STAR Market. Stock code: 688622. The number of A shares publicly issued this time is 17.5 million shares, the issue price is CNY 17.7/share, and the opening price is CNY 92.11 /share.